Emerging Strategies for The Safe and Effective Treatment Of Uncontrolled Diabetes And The Availability Of The Novel Fixed Ratio Combination Insulin /Glp-1 Ras
This activity will review data associated with GLP-1 RA and insulin fixed-ratio combination therapy and when patients should start on these agents to control T2DM.
An American Journal of Managed Care Medical Crossfire®: Management of Newer Ultra–Long–Acting Basal Insulin Agents in Diabetes
This Medical Crossfire will highlight the safety and efficacy data related to the newer generation, ultra–long-acting insulins and their place in therapy.
Evaluating New–Generation Basal Insulin Therapy
This supplement will provide managed care professionals with an overview of diabetes, the status of diabetes control in the U.S., and related comorbidities.
The Advent of Insulin and GLP–1 RA Fixed–Ratio Agents for Uncontrolled Diabetes: Moving Past the Barriers of Clinical Inertia
At the completion of this activity, the participant will be able to analyze barriers that impact treatment intensification in diabetes.